Trial Profile
Long-term efficacy and safety of istradefylline for the treatment of advanced Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2020
Price :
$35
*
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 27 Jul 2016 Status changed from active, no longer recruiting to completed.
- 13 May 2016 New trial record